Comparing two saves of the same URL.

Saved content diff

https://www.mhlw.go.jp/stf/newpage_21273.html

Before

新型コロナウイルス治療薬の特例承認について｜厚生労働省

Saved at: April 10, 2026 at 09:00 AM

View this save

After

新型コロナウイルス治療薬の特例承認について｜厚生労働省

Saved at: July 12, 2026 at 04:20 PM

Open compared save

Change summary

AI summary changedMain text changedVisual appearance changed

Changed blocks

Added lines

Removed lines

AI summary diff

Before

This page announces the special approval of a COVID-19 therapeutic drug by the Ministry of Health, Labour and Welfare on September 27, 2021. Under Article 14-3 of the Pharmaceutical Affairs Law, GlaxoSmithKline K.K.'s "Zebuddy Intravenous Drip Injection 500mg" (generic name: Sotrovimab) has been granted special approval as a treatment for SARS-CoV-2 infection. The application was submitted on September 6, 2021.

After

Text diff

Changed · Lines 2/2

Before

言語切替
日本語

After

Language
Japanese

Changed · Lines 1/1

Before

日本語

After

Japanese

Changed · Lines 2/2

Before

言語切替
日本語

After

Language
Japanese

Changed · Lines 1/1

Before

日本語

After

Japanese

Removed · Lines 1/0

Before

厚生労働省広報基本指針

Screenshot comparison

Previous screenshot

Latest screenshot

Before After Change summary